FBXL3

''FBXL3'' is a gene in humans and mice that encodes the F-box/LRR-repeat protein 3 (FBXL3).
FBXL3 is a member of the F-box protein family, which constitutes one of the four subunits in the SCF ubiquitin ligase complex.

The FBXL3 protein participates in the negative feedback loop responsible for generating molecular circadian rhythms in mammals by binding to the CRY1 and CRY2 proteins to facilitate their polyubiquitination by the SCF complex and their subsequent degradation by the proteasome.

Discovery

The ''Fbxl3'' gene function was independently identified in 2007 by three groups, led by Michele Pagano, Joseph S. Takahashi, Dr. Patrick Nolan and Michael Hastings, respectively. Takahashi used forward genetics N-ethyl-N-nitrosourea (ENU) mutagenesis to screen for mice with varied circadian activity which led to the discovery of the ''Overtime'' (''Ovtm'') mutant of the ''Fbxl3'' gene. Nolan discovered the ''Fbxl3'' mutation ''After hours'' (''Afh'') by a forward screen assessing wheel activity behavior of mutagenized mice. The phenotypes identified in mice were mechanistically explained by Pagano who discovered that the FBXL3 protein is necessary for the reactivation of the CLOCK and BMAL1 protein heterodimer by inducing the degradation of CRY proteins.

''Overtime''

Mice with the homozygous mutation of ''Ovtm'', free run with an intrinsic period of 26 hours. ''Overtime'' is a loss of function mutation caused by a substitution of isoleucine to threonine in the region of FBXL3 that binds to CRY. In mice with this mutation, levels of the proteins PER1 and PER2 are decreased, while levels of CRY proteins do not differ from those of wild type mice. The stabilization of CRY protein levels leads to continued repression of ''Per1'' and ''Per2'' transcription and translation.

''After-hours''

The ''After-hours'' mutation is a substitution of cysteine to serine at position 358. Similar to ''Overtime'', the mutation occurs in the region where FBXL3 binds to CRY. Mice homozygous for the ''Afh'' mutation have a free running period of about 27 hours. The ''Afh'' mutation delays the rate of CRY protein degradation, therefore affecting the transcription of PER2 protein.

''Fbxl21''

The closest homologue to ''Fbxl3'' is ''Fbxl21'' as it also binds to the CRY1 and CRY2 proteins. Predominantly localized to the cytosol, ''Fbxl21'' has been proposed to antagonize the action of ''Fbxl3'' through ubiquitination and stabilization of CRY proteins instead of leading it to degradation. FBXL21 is expressed predominantly in the suprachiasmatic nucleus, which is the region in the brain that functions as the master pacemaker in mammals.

Characteristics

The human ''FBXL3'' gene is located on the long arm of chromosome 13 at position 22.3. The protein is composed of 428 amino acids and has a mass of 48,707 Daltons. The FBXL3 protein contains an F-box domain, characterized by a 40 amino acid motif that mediates protein-protein interactions, and several tandem leucine-rich repeats used for substrate recognition. It has eight post-translational modification sites involving ubiquitination and four sites involving phosphorylation. The FBXL3 protein is predominantly localized to the nucleus. It is one of four subunits of a ubiquitin ligase complex called SKP1-CUL1-F-box-protein, which includes the proteins CUL1, SKP1, and RBX1.

Function

The FBXL3 protein plays a role in the negative feedback loop of the mammalian molecular circadian rhythm. The PER and CRY proteins inhibit the transcription factors CLOCK and BMAL1. The degradation of PER and CRY prevent the inhibition of the CLOCK and BMAL1 protein heterodimer. In the nucleus, the FBXL3 protein targets CRY1 and CRY2 for polyubiquitination, which triggers the degradation of the proteins by the proteasome. FBXL3 binds to CRY2 by occupying its flavin adenine dinucleotide (FAD) cofactor pocket with a C-terminal tail and buries the PER-binding interface on the CRY2 protein.

The FBXL3 protein is also involved in a related feedback loop that regulates the transcription of the ''Bmal1'' gene. ''Bmal1'' expression is regulated by the binding of REV-ERBα and RORα proteins to retinoic acid-related orphan receptor response elements (ROREs) in the ''Bmal1'' promoter region. The binding of the REV-ERBα protein to the promoter represses expression, while RORα binding activates expression. FBXL3 decreases the repression of ''Bmal1'' transcription by inactivating the REV-ERBα and HDAC3 repressor complex.

The FBXL3 protein has also been found to cooperatively degrade c-MYC when bound to CRY2. The c-MYC protein is a transcription factor important in regulating cell proliferation. The CRY2 protein can function as a co-factor for the FBXL3 ligase complex and interacts with phosphorylated c-MYC. This interaction promotes the ubiquitination and degradation of the c-MYC protein.

Interactions

FBXL3 has been shown to interact with:
* SKP1A
* CRY1
* CRY2
* REV-ERBα
* HDAC3
* c-MYC

References

{{Reflist, 32em